Gemini Therapeutics
Cambridge, US · Founded 2015 · Delaware corporation · 2 known investors
Biotech
Founders & leadership
JM
James McLaughlinExecutive Officer, Director
JR
Jason RhodesDirector
CG
Carl GordonDirector
JG
Jean GeorgeDirector
Investors · 2
Reported raises · per SEC filings
Form D private placements▶$2MraisedMay 2016 · 4 investors · BiotechnologyRule 506(b)
▶$2MraisedMay 2016 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jean GeorgeDirector
- James McLaughlinExecutive Officer, Director
- Jason RhodesDirector
- Carl GordonDirector
- Offering amount
- $2M
- Amount sold
- $2M
- First sale
- Apr 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.